基于器官的个性化医学:从瘤结局预测到自身移植
Abel Soto-Gamez1,2, Jeremy P Gunawan1,2, Lara Barazzuol1,2
1Department of Biomedical Sciences, University of Groningen (RUG) and University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Stem cells (Dayton, Ohio)
|March 25, 2024
概括
通过模拟个体疾病特征,患者衍生器官为个性化医疗提供了强大的工具. 这些先进的模型有助于诊断,预测治疗反应,并开发新的基于细胞的疗法.
科学领域:
- 生物技术是生物技术.
- 再生医学是一种再生医学.
- 基因组学就是基因组学.
背景情况:
- 个体的变异性显著影响疾病易感性和治疗疗效.
- 器官技术为捕捉患者特异性的表型变异提供了一个有希望的途径.
- 来自患者的有机体比传统的细胞培养提供了比传统细胞培养更准确的组织动态表示.
研究的目的:
- 审查针对个性化医疗的患者衍生器官的进展.
- 探索诊断,疾病预后和治疗结果预测中的应用.
- 讨论有机体在移植和基于细胞的疗法中的潜力.
主要方法:
- 使用干细胞衍生的3D有机体模型.
- 开发患者特有的有机体培养.
- 分析有机体功能和分子洞察力.
- 审查临床前和临床试验数据.
主要成果:
- 有机体精确地模仿组织组织和组织功能.
- 患者衍生器官在疾病诊断和预后方面显示出潜力.
- 有机器人可以预测个体对治疗的反应.
- 自体有机体为移植提供了基因相容性兼容的来源.
结论:
- 患者衍生器官正在推进个性化医疗应用.
- 目前正在进行临床试验,以验证基于有机体的策略.
- 有机体技术的广泛临床实施仍然存在挑战.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523


